BullFrog AI Holdings (BFRGW) Asset Utilization Ratio (2025 - 2026)
BullFrog AI Holdings' (BFRGW) quarterly Asset Utilization Ratio came in at 0.06 in Q2 2026, up 49.34% quarter-over-quarter from 0.04 in Q4 2025.
Powered by 
Analysis
BullFrog AI Holdings (BFRGW) Asset Utilization Ratio (2025 - 2026) Analysis & Trends
BullFrog AI Holdings (BFRGW) has reported Asset Utilization Ratio for 2 consecutive years, with 0.06 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Asset Utilization Ratio changed N/A year-over-year to 0.06; the trailing twelve-month figure through Jun 2026 stood at 0.06 (changed N/A YoY), and the FY2025 full-year result was 0.03, changed N/A from the prior year.
- Asset Utilization Ratio advanced to 0.06 in Q2 2026 per BFRGW's latest filing, from 0.04 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 0.07 in Q3 2025 and bottomed at 0.04 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.66 Bn | 197.67 Bn | 7.24 Bn | 0.40 |
| 2 | Gilead Sciences | 181.20 Bn | 178.03 Bn | 6.22 Bn | 0.58 |
| 3 | Vertex Pharmaceuticals | 132.30 Bn | 124.45 Bn | 2.84 Bn | 0.47 |
| 4 | Regeneron Pharmaceuticals | 82.63 Bn | 74.64 Bn | 3.93 Bn | 0.38 |
| 5 | Argenx Se | 61.60 Bn | 56.41 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.55 Bn | 49.41 Bn | 52.00 Mn | 0.20 |
| 7 | Alnylam Pharmaceuticals | 34.01 Bn | 30.71 Bn | 992.69 Mn | 0.90 |
| 8 | Biogen | 31.26 Bn | 29.97 Bn | 1.96 Bn | 0.33 |
| 9 | Roivant Sciences | 29.87 Bn | 29.87 Bn | 1.16 Mn | 0.00 |
| 10 | BullFrog AI Holdings | 1.84 Mn | -5.08 Mn | 106,899.00 | 0.06 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.06 |
| Dec 31, 2025 | 0.04 |
| Sep 30, 2025 | 0.07 |